Why all newborn hip screening programs have same results—a mini review

All newborns are screened for developmental dysplasia of the hip (DDH), but countries have varying screening practices. The aim of this narrative mini review is to discuss the controversies of the screening and why it seems that all screening programs are likely to have same outcome. Different scree...

Full description

Saved in:
Bibliographic Details
Published in:European journal of pediatrics 2024-07, Vol.183 (7), p.2889-2892
Main Authors: BM, Matias Vaajala, Pakarinen, Oskari, Helenius, Ilkka, Uimonen, Mikko M, Ponkilainen, Ville T, Kuitunen, Ilari
Format: Article
Language:English
Subjects:
Hip
Hip joint
Hospitals
Medicine
Medicine & Public Health
Mini Review
Neonates
Orthopedics
Pediatrics
Ultrasonic imaging
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:All newborns are screened for developmental dysplasia of the hip (DDH), but countries have varying screening practices. The aim of this narrative mini review is to discuss the controversies of the screening and why it seems that all screening programs are likely to have same outcome. Different screening strategies are discussed alongside with other factors influencing DDH in this review. Universal ultrasound (US) has been praised as it finds more immature hips than clinical examination, but it has not been proven to reduce the rates of late-detected DDH or surgical management. Universal US screening increases initial treatment rates, while selective US and clinical screening have similar outcomes regarding late detection rates than universal US. This can be explained by the extrinsic factor affecting the development of the hip joint after birth and thus initial screening during the early weeks cannot find these cases.   Conclusion : It seems that DDH screening strategies have strengths and limitations without notable differences in the most severe outcomes (late-detected cases requiring operative treatment). Thus, it is important to acknowledge that the used screening policy is a combination of values and available resources rather than a decision based on clear evidence.
ISSN:1432-1076
0340-6199
1432-1076
DOI:10.1007/s00431-024-05539-x